Stay updated on Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record shows the status updated to Terminated on 2026-07-28 with a Business Reason indicating no longer looking for participants, replacing the prior Completed status.
    Difference
    0.2%
    Check dated 2026-08-01T14:12:55.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This reflects a new entry in the study page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T10:16:48.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study record now indicates completion and recruitment is closed. Enrollment has ended and no new participants will be enrolled.
    Difference
    0.0%
    Check dated 2026-07-18T03:48:11.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, representing a minor update to the site. No user-facing content changes are indicated in the provided context.
    Difference
    0.0%
    Check dated 2026-07-03T21:45:03.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    - Revision label updated from v3.6.0 to v3.6.2, indicating a new page build. The change does not modify study content or data displayed on the page.
    Difference
    0.0%
    Check dated 2026-06-26T23:57:18.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label was updated from 'Intervention / Treatment' to 'Intervention/Treatment'. Recruitment status was updated to 'No longer looking for participants' and the site revision footer changed from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T14:19:20.000Z thumbnail image

Stay in the know with updates to Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab+Pembrolizumab in Hematologic Malignancies Clinical Trial page.